Omicron variant of SARS-CoV-2 exhibits an increased resilience to the antiviral type I interferon response
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
In: bioRxiv, 2022.01.20.476754, 10 S.
- Event
-
Veröffentlichung
- (where)
-
Frankfurt am Main
- (who)
-
Universitätsbibliothek Johann Christian Senckenberg
- (when)
-
2022
- DOI
-
10.1101/2022.01.20.476754
- URN
-
urn:nbn:de:hebis:30:3-730019
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:56 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Shalamova, Lyudmila
- Felgenhauer, Ulrike
- Schaubmar, Andreas
- Büttner, Kathrin
- Widera, Marek
- Ciesek, Sandra
- Weber, Friedemann
- Universitätsbibliothek Johann Christian Senckenberg
Time of origin
- 2022
Other Objects (12)
Phänotyp und Funktion humaner CD1c-positiver dendritischer Zellen : Bedeutung für die Hepatitis-C-Virus-Infektion
Omicron variant of SARS-CoV-2 exhibits an increased resilience to the antiviral type I interferon response
Development of antiviral strategies against positive-sense single stranded RNA viruses
Characterization of antiviral effects of emricasan and SARS-CoV-2 isolates in vitro
Reduced interferon antagonism but similar drug sensitivity in Omicron variant compared to Delta variant SARS-CoV-2 isolates
SARS-CoV-2 Omicron variant virus isolates are highly sensitive to interferon treatment
SARS-CoV-2 Omicron variant virus isolates are highly sensitive to interferon treatment
Lack of antiviral activity of darunavir against SARS-CoV-2
Synergism of interferon-beta with antiviral drugs against SARS-CoV-2 variants
Recapitulation of the hepatitis C virus life cycle in engineered murine cell lines
Utility of different surrogate enzyme-linked immunosorbent assays (sELISAs) for detection of SARS-CoV-2 neutralizing antibodies
SARS-CoV-2 Omicron variants: burden of disease, impact on vaccine effectiveness and need for variant-adapted vaccines
Phänotyp und Funktion humaner CD1c-positiver dendritischer Zellen : Bedeutung für die Hepatitis-C-Virus-Infektion
Omicron variant of SARS-CoV-2 exhibits an increased resilience to the antiviral type I interferon response
Development of antiviral strategies against positive-sense single stranded RNA viruses
Characterization of antiviral effects of emricasan and SARS-CoV-2 isolates in vitro
Reduced interferon antagonism but similar drug sensitivity in Omicron variant compared to Delta variant SARS-CoV-2 isolates
SARS-CoV-2 Omicron variant virus isolates are highly sensitive to interferon treatment
SARS-CoV-2 Omicron variant virus isolates are highly sensitive to interferon treatment
Lack of antiviral activity of darunavir against SARS-CoV-2
Synergism of interferon-beta with antiviral drugs against SARS-CoV-2 variants
Recapitulation of the hepatitis C virus life cycle in engineered murine cell lines
Utility of different surrogate enzyme-linked immunosorbent assays (sELISAs) for detection of SARS-CoV-2 neutralizing antibodies
SARS-CoV-2 Omicron variants: burden of disease, impact on vaccine effectiveness and need for variant-adapted vaccines
Phänotyp und Funktion humaner CD1c-positiver dendritischer Zellen : Bedeutung für die Hepatitis-C-Virus-Infektion
Omicron variant of SARS-CoV-2 exhibits an increased resilience to the antiviral type I interferon response
Development of antiviral strategies against positive-sense single stranded RNA viruses
Characterization of antiviral effects of emricasan and SARS-CoV-2 isolates in vitro
Reduced interferon antagonism but similar drug sensitivity in Omicron variant compared to Delta variant SARS-CoV-2 isolates
SARS-CoV-2 Omicron variant virus isolates are highly sensitive to interferon treatment
SARS-CoV-2 Omicron variant virus isolates are highly sensitive to interferon treatment
Lack of antiviral activity of darunavir against SARS-CoV-2
Synergism of interferon-beta with antiviral drugs against SARS-CoV-2 variants
Recapitulation of the hepatitis C virus life cycle in engineered murine cell lines
Utility of different surrogate enzyme-linked immunosorbent assays (sELISAs) for detection of SARS-CoV-2 neutralizing antibodies